Courtesy of the SBHCI. This is the first randomized study comparing a durable-polymer drug-eluting stent (zotarolimus-eluting stent Onyx) and a polymer-free drug-eluting stent (biolimus-A9-coated stent BioFreedom), with only one month of dual antiplatelet therapy in patients at high risk for bleeding. Onyx ONE was a study conducted at 84 sites that randomized 1:1 2000 total patients at…
TCT 2019 | TWILIGHT: Minimal DAPT in High Bleeding Risk Patients
Courtesy of the SBHCI. Monotherapy with a P2Y12 inhibitor after a minimum period (3 months) of dual antiplatelet antiaggregation (DAPT) is a valid treatment option to reduce bleeding in patients at high risk of bleeding complications. The present double-blind study presented at TCT 2019 simultaneously published in NEJM analyzed ticagrelor monotherapy (prior 3 months DAPT)…
TCT 2019
Discover the highlights of the 2019 TCT Congress, which took place between September 25th – 29th at the Moscone Center, San Francisco, CA, Estados Unidos. If you cannot view the articles, click here
Latin American Session at TCT 2019
Yesterday, Wednesday 25th September 2019, took place the session entitled The Best Intervention from Latin América at TCT 2019, one of the most relevant interventional cardiologist events in the world. In this occasion, before a packed room, prestigious Latin American professionals, most SOLACI members, discussed structural interventions, TAVR, MitraClip, CTO, complex cases, and plenty more. This…
Submit a Case for the TCT International Fellow Session
The TCT 2019 Congress, one of the most important interventional cardiology events worldwide, will take place from September 25th to September 29th. SOLACI encourages all Latin American interventional cardiology fellows to submit challenging cases for the International Fellow Session of such Congress. The top three challenging cases will be presented by the winners. Criteria for…